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Objective: To describe the methods used to validate asthma diagnoses in electronic health 
records and summarize the results of the validation studies. 
Background: Electronic health records are increasingly being used for research on asthma 
to inform health services and health policy. Validation of the recording of asthma diagnoses 
in electronic health records is essential to use these databases for credible epidemiological 
asthma research.
Methods: We searched EMBASE and MEDLINE databases for studies that validated asthma 
diagnoses detected in electronic health records up to October 2016. Two reviewers independently 
assessed the full text against the predetermined inclusion criteria. Key data including author, 
year, data source, case definitions, reference standard, and validation statistics (including sen-
sitivity, specificity, positive predictive value [PPV], and negative predictive value [NPV]) were 
summarized in two tables.
Results: Thirteen studies met the inclusion criteria. Most studies demonstrated a high validity 
using at least one case definition (PPV >80%). Ten studies used a manual validation as the ref-
erence standard; each had at least one case definition with a PPV of at least 63%, up to 100%. 
We also found two studies using a second independent database to validate asthma diagnoses. 
The PPVs of the best performing case definitions ranged from 46% to 58%. We found one study 
which used a questionnaire as the reference standard to validate a database case definition; the 
PPV of the case definition algorithm in this study was 89%. 
Conclusion: Attaining high PPVs (>80%) is possible using each of the discussed validation 
methods. Identifying asthma cases in electronic health records is possible with high sensitivity, 
specificity or PPV, by combining multiple data sources, or by focusing on specific test measures. 
Studies testing a range of case definitions show wide variation in the validity of each defini-
tion, suggesting this may be important for obtaining asthma definitions with optimal validity. 
Keywords: sensitivity, specificity, PPV, NPV, database, validity, epidemiology
Background
Asthma is one of the most common chronic diseases, and its core symptoms are 
cough, wheeze, breathlessness, and chest tightness.1 There is no cure, but with the 
right treatment, symptoms ranging from mild attacks to severe and life-threatening 
exacerbations2 can be managed.1 Despite this, a sizeable percentage of asthma patients 
are poorly controlled.3,4
Electronic health records (EHRs) have been widely adopted, which allows for the 
construction of large population-based patient databases. The availability of these 
routinely generated longitudinal records for research has greatly increased over the 
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last decades.5 However, the accuracy of diagnoses recorded 
in these large databases may be low, which would introduce 
bias into studies using the data. Unless the data are validated 
for research, the quality of studies generated from EHRs 
may be debatable.6–9 Furthermore, the validity of different 
disease definitions is not always the same in a given dataset. 
Some diseases (such as asthma) might be coded using less 
specific symptoms, whereas the validity of diagnoses with 
very specific symptoms (such as tension pneumothorax) is 
likely to be better. 
EHRs predominantly store information about diagnoses 
as clinical codes. A single code, or a case definition consist-
ing of multiple codes (with or without additional information 
such as tests or prescribing) can be used to retrieve records 
from EHRs, and additional restrictions can be applied such 
as age or exclusion of other diseases.9,10 Validity of coding 
is generally assessed by comparing a code (or algorithm) to 
1) the diagnosis as verified by the treating physician either 
by manual review of the chart notes or in clinic, 2) a refer-
ence standard such as another linked dataset, or 3) a patient 
questionnaire.10 A previous systematic review by Sharifi et al 
reviewed validation methods to capture acute bronchospasm 
in administrative or claims data;11 this review identified two 
validation studies of bronchospasm codes.12,13 However, the 
study was limited to administrative and claims databases, 
from the United States and Canada. Al Sallakh et al explored 
approaches to defining asthma or assessing asthma outcomes 
using EHR-derived data in the recent literature (calendar 
years 2014 and 2015) and examined the clarity of report-
ing.14 This systematic review focuses on how asthma was 
defined and does not include an overview of test measures 
or validation statistics. 
There is currently no consensus on approaches to defining 
asthma or assessing asthma outcomes using EHR-derived 
data. We explored these approaches in the recent literature 
and examined the clarity of reporting.
Research objective
The primary objectives of this systematic review are to pro-
vide an overview of the methods used in the literature for 
validating asthma diagnosis in EHRs, and the corresponding 
estimates of the validation test measures.
Methods
The methods are described in detail in the study protocol.15 
We searched MEDLINE and EMBASE up to October 2016 
for relevant articles. Our search strategy was composed of 
the following sets of terms: 1) electronic health records or 
databases AND 2) validity or validation or case definition 
or algorithm or sensitivity or specificity or positive predic-
tive value or negative predictive value AND 3) the medical 
subject heading terms for asthma. Reference lists of articles 
of interest were reviewed to add potential additional studies 
in which a validation of asthma diagnosis was done. The 
PRISMA flow diagram can be found in Figure 1 and the 
search strategy can be found in the supplementary material. 
We considered any type of observational study design that 
used EHR to validate the recording of a diagnosis of asthma. 
In addition, we required a clear case definition to define 
asthma from EHR, including a description of the validation 
of said case definition through at least one test measure 
(sensitivity, specificity, positive predictive value [PPV] or 
negative predictive value [NPV]). Two investigators (FN and 
SW) separately assessed the abstracts and full text of each 
potential study against our inclusion criteria; disagreements 
were resolved through a third investigator or by discussion 
to reach consensus. The first author extracted all relevant 
data regarding methodologic elements of included studies; 
author, year of publication, country, time period, date, data 
source, population, case characteristics, clinical events, algo-
rithms, reference standard, and validation statistics. Bias was 
assessed using QUADAS-2 tailored to this specific review.16
The questions of interest for this systematic review are: 1) 
which EHR databases were used to obtain information on the 
diagnosis of asthma? 2) Which case definitions, algorithms or 
codes were used to define an asthma diagnosis? 3) How were 
the diagnostic criteria applied to the data sources and which 
other approaches  have been used to validate a case definition 
algorithm? and 4) What are the estimates for the PPV, NPV, 
specificity, and sensitivity for a diagnosis of asthma in an EHR?
Inclusion criteria
Any type of observational study design which validated the 
recording of an asthma diagnosis in EHR was considered. 
Articles were only considered if published in English and 
published before October 2016 without any specific start date. 
Within the databases, we considered asthma diagnoses based 
on both structured data (such as laboratory results and pre-
scriptions) and unstructured data (such as spirometry results). 
We required the validation case definitions to be compared 
to an external reference standard, such as a manual review, 
questionnaires (completed by the patient or their physician) 
or an independent second database. We included case defini-
tions formed of single codes, those requiring multiple case 
characteristics, and case definitions generated by natural 
language processing (NLP) and/or machine-learning.
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Exclusion criteria
EHRs are a digital reflection of the key facts a health care 
provider needs to record in order to facilitate ongoing and 
potentially complex clinical care. By contrast, the main 
purpose of administrative claims data is administration of 
reimbursements to health care providers for their services. 
This systematic review included only studies from EHRs, 
as the quality measures between the two types of data can 
be markedly different; studies using administrative claims 
data were excluded. Studies involving pharmacovigilance 
databases (signal detection or spontaneous reporting), stud-
ies without validation of asthma recording, and conference 
abstracts were excluded.17,18
Data synthesis
Studies and study data were managed using EndNote and 
Microsoft Excel, respectively. 
The methods for validation of asthma recording in the 
included studies were outlined in a narrative synthesis. 
In addition, Table 1 summarizes the methods and Table 2 
describes the results, consisting of the recorded PPV, NPV, 
sensitivity, and specificity of the included studies.
Dissemination and ethics
This study is a synthesis of previously published studies, 
so no ethical approval is required. The protocol was regis-
tered in the PROSPERO database with registration number 
CRD42016041798, and the protocol has been published.15 
Results from this systematic review can be used to study 
outcome research on asthma and can be used to identify case 
definitions for asthma.
Results
In total, 1,346 titles were found in the EMBASE and MED-
LINE databases, of which 946 were non-duplicates. Of those, 
54 articles were reviewed in full text and we found 13 articles 
that contained a validation process of asthma diagnosis that 
met all eligibility criteria. Characteristics of the 13 included 
studies ordered by year of publication are summarized in 
Table 1, and the study results are displayed in Table 2. The 
asthma prevalence necessary for the interpretation of PPVs 
and NPVs is presented in Table 1, where available.
The reference standard used to validate the asthma diag-
nosis in the EHRs differed between the studies: ten studies 
used manual validation by a clinician, two studies compared 
Figure 1 Study screening process: PRISMA flow diagram. 
Note: Reproduced from Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic Reviews and meta-analyses: the PRISMA 
statement. BMJ. 2009;339:b2535.37
Abbreviation: EHR, electronic health record.
EMBASE
up to 31/10/16
1014 citation(s)
MEDLINE
up to 31/10/16
332 citation(s)
References
4 citation(s)
946 non-duplicate
citations screened
Inclusion/exclusion
criteria applied
892 articles excluded
after title/abstract screen
54 articles retrieved
Inclusion/exclusion
criteria applied
13 articles included
36 articles excluded
after full text screen
no validation process was described
5 articles excluded
during data extraction
face validation or no EHR validation
 
Cl
in
ica
l E
pi
de
m
io
lo
gy
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
19
4.
80
.2
29
.2
44
 o
n 
06
-J
an
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Clinical Epidemiology 2017:9submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
646
Nissen et al
A
ut
ho
r,
 y
ea
r,
 
co
un
tr
y,
 (
pe
ri
od
)
D
at
a 
so
ur
ce
, p
op
ul
at
io
n
Sa
m
pl
e/
ca
se
 
ch
ar
ac
te
ri
st
ic
s
C
lin
ic
al
 e
ve
nt
A
lg
or
it
hm
V
al
id
at
io
n
M
an
ua
l v
al
id
at
io
n
X
i e
t 
al
,19
 2
01
5
C
an
ad
a
2 
la
rg
e 
ac
ad
em
ic
 p
ri
m
ar
y 
ca
re
 
cl
in
ic
s
Pr
im
ar
y 
ca
re
 
39
8 
ra
nd
om
ly
 s
el
ec
te
d 
pa
tie
nt
s
16
 y
ea
rs
 a
nd
 o
ld
er
 
A
st
hm
a 
co
de
C
O
PD
 c
od
e
O
th
er
 r
es
pi
ra
to
ry
 
co
nd
iti
on
 c
od
e
O
th
er
 c
on
di
tio
n 
co
de
 
Se
ar
ch
 a
lg
or
ith
m
s:
1.
 A
st
hm
a 
in
 d
is
ea
se
 r
eg
is
tr
y
2.
 B
ill
in
g 
co
de
3.
 A
st
hm
a 
in
 C
PP
4.
 A
st
hm
a 
m
ed
ic
at
io
ns
5.
 A
st
hm
a 
in
 c
ha
rt
 n
ot
es
6.
 A
st
hm
a 
in
 C
PP
 O
R
 b
ill
in
g 
co
de
 4
93
7.
 A
st
hm
a 
in
 C
PP
 O
R
 b
ill
in
g 
co
de
 4
93
 (
ex
cl
us
io
n 
co
de
s 
49
1,
 4
92
, a
nd
 4
96
)
8.
 (
A
st
hm
a 
in
 c
ha
rt
 n
ot
es
 O
R
 a
st
hm
a 
m
ed
ic
at
io
ns
) 
A
N
D
 b
ill
in
g 
co
de
 4
93
9.
 (
Bi
lli
ng
 c
od
e 
49
3 
O
R
 m
ed
ic
at
io
ns
) 
A
N
D
 a
st
hm
a 
in
 
ch
ar
t 
no
te
s
10
. B
ill
in
g 
di
ag
no
st
ic
 c
od
e 
49
3 
A
N
D
 a
st
hm
a 
in
 c
ha
rt
 n
ot
es
M
an
ua
l r
ev
ie
w
En
ge
lk
es
 e
t 
al
,20
 2
01
4
th
e 
N
et
he
rl
an
ds
 
IC
PI
: D
ut
ch
 G
P 
EH
R
Pr
im
ar
y 
ca
re
 
63
,5
18
 p
ot
en
tia
l c
as
es
 
id
en
tifi
ed
22
,6
99
 c
as
es
 a
fte
r 
au
to
m
at
ed
 t
ex
t 
va
lid
at
io
n
C
hi
ld
re
n 
ag
ed
 5
–1
8
D
efi
ni
te
, p
ro
ba
bl
e,
 
an
d 
do
ub
tfu
l c
as
es
 o
f 
as
th
m
a 
C
om
bi
na
tio
n 
of
 IC
PI
 c
om
m
un
ic
at
io
n 
co
de
s,
 c
lin
ic
ia
n 
co
de
s,
 d
ru
g 
na
m
es
 a
nd
 fr
ee
 t
ex
t 
ge
ne
ra
te
d 
by
 a
 
m
ac
hi
ne
-le
ar
ni
ng
 a
lg
or
ith
m
 (
R
IP
PE
R
)
22
,6
99
 c
as
es
 m
an
ua
lly
 
va
lid
at
ed
, 1
4,
30
3 
as
th
m
a 
ca
se
s 
fo
un
d 
A
fz
al
 e
t 
al
,21
 2
01
3
th
e 
N
et
he
rl
an
ds
Ja
nu
ar
y 
20
00
-Ja
nu
ar
y 
20
12
IC
PI
: D
ut
ch
 G
P 
EH
R
Pr
im
ar
y 
ca
re
 
63
,6
18
 p
ot
en
tia
l a
st
hm
a 
ca
se
s 
id
en
tifi
ed
, c
hi
ld
re
n 
ag
ed
 5
–1
8
D
efi
ni
te
, p
ro
ba
bl
e,
 
an
d 
do
ub
tfu
l c
as
es
 o
f 
as
th
m
a
C
om
bi
na
tio
n 
of
 IC
PI
 c
om
m
un
ic
at
io
n 
co
de
s,
 c
lin
ic
ia
n 
co
de
s,
 d
ru
g 
na
m
es
 a
nd
 fr
ee
 t
ex
t 
ge
ne
ra
te
d 
by
 a
 
m
ac
hi
ne
-le
ar
ni
ng
 a
lg
or
ith
m
 (
R
IP
PE
R
)
5,
03
2 
pa
tie
nt
s 
m
an
ua
lly
 
va
lid
at
ed
 b
y 
cl
in
ic
ia
n
D
ex
he
im
er
 e
t 
al
,22
 
20
13
U
ni
te
d 
St
at
es
1 
pe
di
at
ri
c 
ED
 
15
,1
63
 a
ss
es
se
d,
 1
,1
00
 
as
th
m
a 
pa
tie
nt
s
al
l a
st
hm
a 
pa
tie
nt
s 
(2
–1
8 
ye
ar
s)
 in
 a
 3
 m
on
th
 t
im
e 
w
in
do
w
A
st
hm
a 
co
de
 
Ba
ye
si
an
 n
et
w
or
k 
sy
st
em
, p
re
vi
ou
sl
y 
us
ed
 o
n 
cl
ai
m
s 
da
ta
 (
Sa
nd
er
s)
Pe
di
at
ri
c 
as
th
m
a/
re
sp
ir
at
or
y 
di
st
re
ss
 p
ro
to
co
l fi
lle
d 
in
 fo
r 
id
en
tifi
ed
 p
at
ie
nt
s
W
u 
et
 a
l,2
3  2
01
3,
 
20
14
U
ni
te
d 
St
at
es
 
C
hi
ld
re
n 
en
ro
lle
d 
in
 t
he
 
M
ay
o 
C
lin
ic
 s
ic
k-
ch
ild
 d
ay
ca
re
 
pr
og
ra
m
, S
ec
on
da
ry
 c
ar
e 
11
2 
ch
ild
re
n 
yo
un
ge
r 
th
an
 4
 
IC
D
-9
 c
od
es
N
at
ur
al
 la
ng
ua
ge
 
N
at
ur
al
 la
ng
ua
ge
 p
ro
ce
ss
in
g 
(lo
gi
c)
 N
at
ur
al
 la
ng
ua
ge
 p
ro
ce
ss
in
g 
(m
ac
hi
ne
 le
ar
ni
ng
) 
M
an
ua
l r
ev
ie
w
 b
y 
a 
cl
in
ic
ia
n
K
oz
yr
sk
yj
 e
t 
al
,24
 
20
09
C
an
ad
a
SA
G
E:
 b
ir
th
 c
oh
or
t 
of
 1
6,
32
0 
ch
ild
re
n 
bo
rn
 in
 1
99
5 
in
 
M
an
ito
ba
, C
an
ad
a
Q
ue
st
io
nn
ai
re
 in
 2
00
2 
ha
d 
3,
59
8 
re
sp
on
se
s
M
an
ito
ba
’s
 h
ea
lth
 c
ar
e 
re
gi
st
ry
 
re
co
rd
s 
72
3 
ch
ild
re
n 
fr
om
 t
he
 
gr
ou
p 
w
ith
 c
om
pl
et
ed
 
qu
es
tio
nn
ai
re
s
24
6 
ca
se
s,
 4
77
 c
on
tr
ol
s
 
A
st
hm
a
 
D
at
ab
as
e 
de
fin
iti
on
s 
in
 h
ea
lth
 c
ar
e 
re
co
rd
s
  
Pe
di
at
ri
c 
al
le
rg
is
t 
di
ag
no
si
s 
of
 a
st
hm
a
T
ab
le
 1
 C
ha
ra
ct
er
is
tic
s 
of
 s
tu
di
es
 w
ith
 v
al
id
at
ed
 a
st
hm
a 
al
go
ri
th
m
s
(C
on
tin
ue
d)
 
Cl
in
ica
l E
pi
de
m
io
lo
gy
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
19
4.
80
.2
29
.2
44
 o
n 
06
-J
an
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Clinical Epidemiology 2017:9 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
647
Asthma validation in EHR: systematic review
A
ut
ho
r,
 y
ea
r,
 
co
un
tr
y,
 (
pe
ri
od
)
D
at
a 
so
ur
ce
, p
op
ul
at
io
n
Sa
m
pl
e/
ca
se
 
ch
ar
ac
te
ri
st
ic
s
C
lin
ic
al
 e
ve
nt
A
lg
or
it
hm
V
al
id
at
io
n
Pa
ch
ec
o 
et
 a
l,2
5  2
00
9
U
ni
te
d 
St
at
es
N
U
ge
ne
 P
ro
je
ct
G
en
om
e-
w
id
e 
as
so
ci
at
io
n 
st
ud
y
 
7,
97
0 
pe
op
le
 w
ith
 D
N
A
 
sa
m
pl
es
, o
f w
hi
ch
 5
21
 h
ad
 
an
 a
st
hm
a 
di
ag
no
si
s
 
A
st
hm
a 
di
ag
no
si
s
 
In
it
ia
l a
st
hm
a 
ca
se
s 
al
go
ri
th
m
:
A
st
hm
a 
di
ag
no
sis
 a
nd
 a
st
hm
a 
m
ed
ic
at
io
n 
pr
es
cr
ip
tio
n 
on
 
≥1
 v
isi
t 
A
N
D
 n
o 
ot
he
r 
ch
ro
ni
c 
lu
ng
 d
ise
as
e 
di
ag
no
sis
 o
n 
≥2
 v
isi
ts
 A
N
D
 n
o 
re
po
rt
ed
 s
m
ok
in
g 
hi
st
or
y 
≥1
0 
ye
ar
s 
Fi
na
l a
st
hm
a 
ca
se
s 
al
go
ri
th
m
:
A
st
hm
a 
di
ag
no
si
s 
on
 ≥
1 
vi
si
t 
A
N
D
 a
st
hm
a 
di
ag
no
si
s 
or
 
m
ed
ic
at
io
n 
pr
es
ci
pt
io
n 
on
 ≥
1 
ot
he
r 
vi
si
t 
A
N
D
 n
o 
ot
he
r 
ch
ro
ni
c 
lu
ng
 d
is
ea
se
 d
ia
gn
os
is
 o
n 
≥2
 v
is
its
 A
N
D
 n
o 
re
po
rt
ed
 s
m
ok
in
g 
hi
st
or
y 
≥1
0 
ye
ar
s
In
it
ia
l a
st
hm
a 
co
nt
ro
ls
 a
lg
or
it
hm
:
N
o 
di
ag
no
sis
 fo
r 
an
y 
re
sp
ir
at
or
y 
di
se
as
e 
or
 c
an
ce
r 
A
N
D
 
no
 p
re
sc
ri
pt
io
n 
of
 a
ny
 a
st
ha
/C
O
PD
/im
m
un
od
ep
re
ss
an
t 
m
ed
ic
at
io
n 
A
N
D
 n
o 
re
po
rt
ed
 s
m
ok
in
g 
hi
st
or
y 
≥1
0 
ye
ar
s
Fi
na
l a
st
hm
a 
co
nt
ro
ls
 a
lg
or
it
hm
:
≥2
 v
is
its
 w
ith
 a
ny
 a
st
hm
a 
di
ag
no
si
s 
or
 p
re
sc
ri
pt
io
ns
 
A
N
D
 n
o 
di
ag
no
si
s 
fo
r 
an
y 
re
sp
ir
at
or
y 
di
se
as
e 
or
 li
st
ed
 
ca
nc
er
 A
N
D
 n
o 
pr
es
cr
ip
tio
n 
of
 a
ny
 a
st
hm
a/
C
O
PD
/
im
m
un
od
ep
re
ss
an
t 
m
ed
ic
at
io
n 
A
N
D
 n
o 
re
po
rt
ed
 
sm
ok
in
g 
hi
st
or
y 
≥1
0 
ye
ar
s
M
an
ua
l r
ev
ie
w
 o
f 1
00
 c
as
es
 
fo
r 
bo
th
 a
lg
or
ith
m
s
V
ol
lm
er
 e
t 
al
,26
 2
00
4
U
ni
te
d 
St
at
es
Ju
ly
 1
99
8 
to
 Ja
nu
ar
y 
19
99
K
PN
W
, E
pi
c,
 O
SC
A
R
, T
O
PS
ED
, s
ec
on
da
ry
 c
ar
e
 
23
5,
00
0 
pa
tie
nt
s 
w
ith
 
co
nt
in
uo
us
 h
ea
lth
 p
la
n 
el
ig
ib
ili
ty
 a
ge
d 
15
–5
5 
in
 
Ja
nu
ar
y 
19
99
9,
72
3 
as
th
m
a 
pa
tie
nt
s 
id
en
tifi
ed
 
IC
D
-9
 c
od
es
 
H
ea
lt
h
 c
ar
e 
u
ti
liz
at
io
n
 p
ro
fi
le
s 
u
se
d
 f
o
r 
va
lid
at
io
n 
st
ud
y 
C
ri
te
ri
a 
us
ed
 in
 m
ed
ic
al
 
re
co
rd
s 
re
vi
ew
1.
 F
ou
r 
“h
ig
h-
pr
ob
ab
le
” 
ca
te
go
ri
es
:
→
 T
w
o 
or
 m
or
e 
no
n-
ur
ge
nt
 c
ar
e 
ou
tp
at
ie
nt
 c
on
ta
ct
s 
fo
r 
as
th
m
a
→
 A
 s
in
gl
e 
no
n-
ur
ge
nt
 c
on
ta
ct
 a
nd
 o
ne
 o
r 
m
or
e 
ED
 o
r 
in
pa
tie
nt
 c
on
ta
ct
 fo
r 
as
th
m
a
→
 A
ny
 In
du
st
ri
al
 M
ed
ic
in
e 
vi
si
t 
fo
r 
as
th
m
a
→
 A
ny
 a
st
hm
a 
vi
si
t 
an
d 
ei
th
er
 o
f t
he
 t
w
o 
m
ed
ic
at
io
n 
di
sp
en
si
ng
 c
ri
te
ri
a
2.
 S
in
gl
e 
no
n-
ur
ge
nt
 o
ut
pa
tie
nt
 v
is
it 
on
ly
3.
 F
ou
r 
or
 m
or
e 
β-a
go
ni
st
s,
 w
ith
 o
r 
w
ith
ou
t 
a 
ne
bu
liz
er
 
tr
ea
tm
en
t 
or
de
r,
 b
ut
 n
o 
as
th
m
a 
vi
si
ts
 o
f a
ny
 k
in
d 
an
d 
no
 IC
S 
di
sp
en
si
ng
s
4.
 E
D
 o
r 
ur
ge
nt
 c
ar
e 
vi
si
t 
fo
r 
as
th
m
a 
an
d 
ne
bu
liz
er
 
tr
ea
tm
en
t 
or
de
r,
 b
ut
 n
o 
ot
he
r 
m
ed
ic
at
io
n 
cr
ite
ri
a 
m
et
 
an
d 
no
 o
th
er
 t
yp
es
 o
f a
st
hm
a 
vi
si
ts
5.
 H
os
pi
ta
liz
at
io
n 
fo
r 
as
th
m
a,
 b
ut
 n
ei
th
er
 a
st
hm
a 
m
ed
ic
at
io
n 
cr
ite
ri
on
 m
et
 a
nd
 n
o 
ou
tp
at
ie
nt
 a
st
hm
a 
vi
sit
s 
of
 a
ny
 k
in
d
P
ro
ba
bl
e 
as
th
m
a
• 
T
w
o 
or
 m
or
e 
as
th
m
a 
he
al
th
 c
ar
e 
vi
si
ts
• 
A
 s
in
gl
e 
vi
sit
 fo
r 
as
th
m
a 
w
ith
 
a 
ch
ar
t n
ot
at
io
n 
in
di
ca
tin
g 
a 
pr
io
r 
hi
st
or
y 
of
 a
st
hm
a
• 
A
 s
in
gl
e 
he
al
th
 c
ar
e 
vi
si
t 
fo
r 
ac
tiv
e 
sy
m
pt
om
s 
of
 
as
th
m
a 
(w
he
ez
e,
 c
ou
gh
, 
sh
or
tn
es
s 
of
 b
re
at
h)
• 
A
 s
in
gl
e 
vi
si
t 
fo
r 
an
 a
st
hm
a 
ex
ac
er
ba
tio
n 
th
at
 r
es
po
nd
s 
to
 t
he
ra
py
, e
ve
n 
if 
no
 p
ri
or
 
hi
st
or
y
P
os
si
bl
e 
as
th
m
a
• 
Pa
tie
nt
-r
ep
or
te
d 
hi
st
or
y 
of
 
as
th
m
a 
no
te
d 
in
 c
ha
rt
, b
ut
 
no
 e
vi
de
nc
e 
of
 a
ct
iv
e 
as
th
m
a 
or
 t
re
at
m
en
t 
fo
r 
as
th
m
a
T
ab
le
 1
 (C
on
tin
ue
d)
(C
on
tin
ue
d)
 
Cl
in
ica
l E
pi
de
m
io
lo
gy
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
19
4.
80
.2
29
.2
44
 o
n 
06
-J
an
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Clinical Epidemiology 2017:9submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
648
Nissen et al
A
ut
ho
r,
 y
ea
r,
 
co
un
tr
y,
 (
pe
ri
od
)
D
at
a 
so
ur
ce
, p
op
ul
at
io
n
Sa
m
pl
e/
ca
se
 
ch
ar
ac
te
ri
st
ic
s
C
lin
ic
al
 e
ve
nt
A
lg
or
it
hm
V
al
id
at
io
n
6.
 E
D
 o
r 
ur
ge
nt
 c
ar
e 
vi
si
t 
fo
r 
as
th
m
a,
 b
ut
 n
o 
ot
he
r 
ty
pe
s 
of
 a
st
hm
a 
vi
si
ts
 a
nd
 n
o 
as
th
m
a 
m
ed
ic
at
io
n 
cr
ite
ri
a 
m
et
• 
A
n 
un
co
rr
ob
or
at
ed
 E
D
 
di
ag
no
si
s 
of
 a
st
hm
a
7.
 N
eb
ul
iz
er
 t
re
at
m
en
t 
bu
t 
no
 a
st
hm
a 
vi
si
ts
 o
f a
ny
 k
in
d 
an
d 
no
 o
th
er
 m
ed
ic
at
io
n 
cr
ite
ri
a 
m
et
• 
D
ia
gn
os
is
 o
f “
ru
le
 o
ut
 
as
th
m
a”
 w
ith
 n
o 
cl
ea
r 
re
so
lu
tio
n
8.
 A
ll 
ot
he
r 
ca
se
s
D
on
ah
ue
 e
t 
al
,27
 1
99
7
U
ni
te
d 
St
at
es
 
H
ar
va
rd
 P
ilg
ri
m
 H
ea
lth
 C
ar
e 
(H
PH
C
); 
Pr
im
ar
y,
 s
ec
on
da
ry
 
an
d 
em
er
ge
nc
y 
ca
re
 
R
an
do
m
 s
am
pl
e 
of
 1
00
 
pa
tie
nt
s
 
A
st
hm
a 
co
de
 
A
st
hm
a 
di
ag
no
si
s 
an
d 
as
th
m
a 
dr
ug
 d
is
pe
ns
in
g 
M
an
ua
l r
ev
ie
w
 b
y 
cl
in
ic
ia
ns
Pr
em
ar
at
ne
 e
t 
al
,28
 
19
97
U
ni
te
d 
K
in
gd
om
19
94
A
cc
id
en
t 
an
d 
ED
s 
of
 t
w
o 
ho
sp
ita
ls
A
ll 
as
th
m
a 
pa
tie
nt
s 
Ja
nu
ar
y-
M
ar
ch
 1
99
4
1,
18
5 
re
co
rd
s,
 o
f w
hi
ch
 
20
9 
di
d 
no
t 
ha
ve
 e
no
ug
h 
da
ta
St
ri
ng
 c
on
ta
in
in
g 
“a
st
h*
”
St
ri
ng
 c
on
ta
in
in
g 
“a
st
h*
” 
in
 t
he
 fr
ee
 t
ex
t 
re
co
rd
s
A
ffi
rm
at
io
n
 o
f 
as
th
m
a 
di
ag
no
si
s:
Fi
na
l d
ia
gn
os
is
 o
f a
st
hm
a 
by
 
cl
in
ic
al
 o
ffi
ce
r 
O
R
 s
ym
pt
om
s 
of
 a
st
hm
a 
an
d 
(h
is
to
ry
 o
f 
as
th
m
a 
or
 b
ro
nc
ho
di
la
to
rs
 
gi
ve
n,
 w
ith
 im
pr
ov
em
en
t)
 
O
R
 k
no
w
n 
as
th
m
at
ic
 
pr
es
en
te
d 
w
ith
 s
ym
pt
om
s 
or
 
fo
r 
m
ed
ic
at
io
n
R
ej
ec
ti
o
n
 o
f 
as
th
m
a 
di
ag
no
si
s:
C
le
ar
 a
lte
rn
at
iv
e 
di
ag
no
si
s
Su
ffi
ci
en
t 
ot
he
r 
in
fo
rm
at
io
n 
to
 r
ej
ec
t 
as
th
m
a 
di
ag
no
si
s
C
om
pa
ri
so
n 
to
 a
n 
in
de
pe
nd
en
t 
da
ta
ba
se
En
ge
la
nd
 e
t 
al
,29
 2
00
9
N
or
w
ay
 
M
BR
N
: p
op
ul
at
io
n-
ba
se
d 
bi
rt
h 
re
gi
st
ry
, a
ll 
bi
rt
hs
 in
 N
or
w
ay
 
si
nc
e 
19
67
 (
m
or
e 
th
an
 2
.3
 
m
ill
io
n)
N
or
PD
: a
ll 
di
sp
en
se
d 
pr
es
cr
ip
tio
ns
 fr
om
 Ja
nu
ar
y 
20
04
 in
 N
or
w
ay
 
10
8,
48
9 
pr
eg
na
nc
ie
s,
 o
f 
w
hi
ch
 4
,5
49
 m
ot
he
rs
 w
er
e 
re
co
rd
ed
 a
s 
ha
vi
ng
 a
st
hm
a 
in
 M
BR
N
A
st
hm
a
A
st
hm
a 
di
ag
no
si
s 
in
 M
BR
N
 
N
or
PD
: a
st
hm
a 
m
ed
ic
at
io
n
 
C
ou
lte
r 
et
 a
l,3
0  1
98
9
U
ni
te
d 
K
in
gd
om
  
7 
ge
ne
ra
l p
ra
ct
ic
es
 in
 t
he
 
O
xf
or
d 
co
m
m
un
ity
 h
ea
lth
 
pr
oj
ec
t
2,
19
9 
pa
tie
nt
s 
on
 m
ed
ic
at
io
n
Pr
im
ar
y 
ca
re
2,
44
3 
on
 d
ig
ita
l r
eg
is
te
r
Br
on
ch
od
ila
to
rs
, i
nh
al
ed
 
C
S,
 p
ro
ph
yl
ac
tic
 d
ru
gs
A
st
hm
a 
di
ag
no
si
s
A
st
hm
a 
di
ag
no
si
s 
on
 r
eg
is
te
r
M
an
ua
l r
ev
ie
w
 a
ga
in
st
 t
he
 
lis
t 
of
 p
at
ie
nt
s 
on
 lo
ng
-t
er
m
 
m
ed
ic
at
io
n 
T
ab
le
 1
 (C
on
tin
ue
d)
(C
on
tin
ue
d)
 
Cl
in
ica
l E
pi
de
m
io
lo
gy
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
19
4.
80
.2
29
.2
44
 o
n 
06
-J
an
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Clinical Epidemiology 2017:9 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
649
Asthma validation in EHR: systematic review
the studied records to independent linked databases and one 
study used patient questionnaires. The test measures also 
differ between the different papers, encompassing sensitiv-
ity, specificity, PPV, and NPV. We focus on 13 studies in this 
review, ordered by reference standard used and by date of 
publication. Bias assessment results using QUADAS-2 are 
presented in Table 3.
Manual validation
We found ten studies that used a manual validation as the 
reference standard. All studies had at least one case definition 
algorithm with a PPV of at least 63%. Where other measure-
ments could be calculated, the studies had at least one case 
definition with a sensitivity of at least 85%, specificity of at 
least 92%, and NPV of at least 94%. Within this group, four 
studies used case definition algorithms generated by machine 
learning. Five studies included only children, while two stud-
ies included only persons older than 16 years.
Xi et al tested a variety of EHR search algorithms based 
on two large academic primary care clinics in Hamilton, 
Canada.19 The reference standard consisted of a physician 
chart review-based diagnosis. The eight case definitions are 
presented in Table 1, and their PPVs in Table 2. The algorithm 
searching for patients who had asthma in their patient profile 
or had an asthma billing code was the most accurate with a 
sensitivity of 90% (95% CI [87% to 93%]) and a specificity 
of 84% (95% CI [80% to 88%]).
Engelkes et al undertook a study to determine the validity 
of case definitions generated by machine learning to define 
asthma cases, based on a previous study be Afzal et al.20,21 
Originating from a large Dutch general practitioner (GP) 
database, the authors manually reviewed 22,699 potential 
asthma cases. Among those, 14,303 asthma cases were found, 
which resulted in a PPV of 63%.
The study by Afzal et al uses the same dataset and 
machine-learning algorithm for definite and potential asthma 
cases as the study by Engelkes et al.20,21 Clinicians manu-
ally validated 5,032 potential asthma cases identified by a 
broad search algorithm out of 63,618 patients. This training 
set was used for the machine-learning algorithm. The test 
measures are measuring the validity of the machine-learning 
algorithm within the smaller population, not of the broad 
search algorithm. The PPV, sensitivity, and specificity for 
three case definition algorithms (definite cases; definite and 
probable cases; definite, probable, and doubtful cases) were 
calculated. The PPVs range from 57% for all definite, prob-
able, and doubtful asthma cases to 82% for only the definite 
asthma cases. A
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(Continued)
Table 2 Characteristics of studies with validated asthma algorithms
Author, year, 
country, prevalence
Algorithm Sensitivity,  
95% CI
Specificity,  
95% CI
PPV,  
95% CI
NPV,  
95% CI
Prevalence
Manual validation
Xi et al,19 2015  1. Asthma in disease registry 7% (5–10) 99% (97–100) 67% (38–87) 73% (72–74) 8.1%
Canada  2. Billing code 77% (75–83) 89.2% (86–92) 74% (67–80) 91% (88–94)  
  3. Asthma in CPP 63% (59–68) 92% (90–95) 76% (68–83) 87% (83–89)  
  4. Asthma medications 79% (75–83) 64% (59–68) 46% (41–50) 88% (84–92)  
  5. Asthma in chart notes 85% (81–88) 76% (72–80) 58% (52–63) 93% (89–95)  
  6. Asthma in CPP OR billing code 493 90% (87–93) 84% (80–88) 69% (63–74) 96% (93–97)  
  7. Asthma in CPP OR billing code 493 
(exclusion codes 491, 492, and 496)
87% (83–90) 85% (82–89) 70% (63–76) 94% (91–96)  
  8. (Asthma in chart notes OR asthma 
medications) AND billing code 493
78% (74–82) 92% (89–95) 79% (72–85) 91% (88–94)  
  9. (Billing code 493 OR medications) 
AND asthma in chart note
 84% (80–88) 84% (80–88) 67% (61–73) 93% (90–95)  
  10. Billing diagnostic code 493 AND 
asthma in chart notes
74% (70–78) 93% (91–96) 81% (73–87) 90% (87–93)  
Engelkes et al,20 2014 Definite, probable and doubtful cases   63%   
Netherlands      
Afzal et al,21 2013 Definite asthma 98% 95% 66%  6%
Netherlands Definite + probable 96% 90% 82%  29%
Definite, probable and doubtful cases 95% 67% 57%  32%
Dexheimer et al,22 
2013
Algorithm constructed using a Bayesian  
network system
  64%  7–10%
United States       
Wu et al,23 2013, 2014 ICD-9 codes 31 93 57 82 4–17%
United States Natural language processing: logic 81 95 84 94  
 Natural language processing: machine 
learning
85 97 88 95  
Kozyrskyj et al,24 2009 At least one asthma hospitalization, or 
two physician visits, or four prescription 
medications
47% (35–60) 92% (78–98) 91% (76–98)  11%
Canada      
 At least one asthma hospitalization, or 
two physician visits, or two prescription 
medications
67% (54–78) 92% (78–98) 94% (82–99)   
      
 At least one asthma hospitalization, or 
one physician visit, or two prescription 
medications
77% (65–87) 92% (78–98) 94% (85–99)   
      
 At least one asthma hospitalization, 
or one physician visit, or two 
bronchodilators, or one controller 
medication
80% (69–89) 89% (74–97) 93% (83–98)   
      
 At least one asthma hospitalization, 
or one physician visit, or two 
bronchodilators, or one bronchodilator 
and ketotifen or an oral steroid, or one 
controller medication
80% (69–89) 89% (74–97) 93% (83–98)   
      
      
 At least one asthma hospitalization, 
or one physician visit, or one 
bronchodilator, or one controller 
medication
82% (70–90) 83% (67–94) 90% (79–96)   
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Table 2 (Continued)
Dexheimer et al evaluated a computerized asthma detec-
tion system in an urban, tertiary care pediatric emergency 
department in a 3-month prospective, randomized controlled 
trial in 2009.22 A Bayesian network system screened all 
emergency department patients for acute asthma. The system 
identified 1,100 patients with asthma exacerbations, of which 
704 were confirmed by a pediatric emergency care physician 
within 3 days of the visit. The PPV for the Bayesian network 
system was 65%. 
Wu et al evaluated the accuracy of a computational 
approach to asthma ascertainment. The authors developed 
an NLP system for extracting predetermined asthma from 
free text in EHRs.23 Manual chart review by a clinician was 
the reference standard. The patient group consisted of 112 
children younger than 4 years. The NLP-generated case 
definition algorithms had a sensitivity of 85%, specificity 
of 97%, PPV of 88%, and an NPV of 95%. For compari-
son, the test measures of the ICD-9 asthma codes were 
calculated (sensitivity 31%, specificity 93%, PPV 57%, 
NPV 82%). 
Kozyrskyj et al described the Study of Asthma, Genes 
and the Environment (SAGE). The study captures the longi-
tudinal health care records of 16,320 children born in 1995 
in Manitoba (Canada) and contains detailed information 
on early-life exposures in relationship to the development 
of asthma.24 Within the birth cohort, a nested case-control 
study with 723 children was partly created to confirm asthma 
status in children and these data were used to validate health 
care database measures of asthma. These 723 children were 
chosen by random sampling from the birth cohort; the par-
ents of 288 children with and 435 without a parental report 
of asthma in the last 12 months agreed to participate. The 
reference standard for the validation consisted of pediatric 
allergist-diagnosed asthma, methacholine challenge tests, and 
Author, year, 
country, prevalence
Algorithm Sensitivity,  
95% CI
Specificity,  
95% CI
PPV,  
95% CI
NPV,  
95% CI
Prevalence
Pacheco et al, 2009 Initial algorithm 70% (60–78) 100% 100% (90–100) 77% (65–86) 7.2%
United States Final algorithm 95% (84–99) 96% (87–99) 95% (84–99) 96% (87–99)  
Vollmer et al,26 2004 Algorithm 1: population of 4460   95%  4.1%
United States Algorithm 2: population of 2334   90%   
 Algorithm 3: population of 545   70%   
 Algorithm 4: population of 25   100%   
 Algorithm 5: population of 11   50%   
 Algorithm 6: population of 721   80%   
 Algorithm 7: population of 99   27%   
 Algorithm 8: population of 1528   80%   
Donahue et al,27 1997 Asthma code and drug dispensing   86%  3%
United States       
Premaratne et al,28 
1997
String containing asth* in free text 
records
80% (75–86) 96% (96–99) 91% (87–94) 94% (93–95) 20.6%
United Kingdom       
Comparison to an independent database
Engeland et al,29 2009 Asthma in MBRN and NorPD 51% (49–52) 98% (98–98) 46% (45–48)  4.20%
Norway       
Coulter et al,30 1989 Percentage of people on long term 
medication and recorded on the register
  58%   
United Kingdom      
Comparison to a questionnaire
Ward et al,31 2004 Total of all reviewed patients   89%  5.60%
United Kingdom Cases without bronchial hyperreactivity   73%   
 Controls with bronchial hyperreactivity   78%   
Abbreviations: PPV, positive predictive value; NPV, negative predictive value; NLP, natural language processing; ML, machine learning; MBRN, Medical Birth Registry of 
Norway; NorPD, Norwegian Prescription Database.
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skin tests. The PPV of asthma definitions varied from 90% 
to 94%, the sensitivity from 47% to 82%, and the specificity 
from 83% to 92%.
Pacheco et al constructed case definitions to identify 
asthmatic patients as cases, and healthy patients as controls 
using data from electronic medical records in the United 
States. This was done to identify asthma patients for future 
genome-wide association studies (GWAS). The case defini-
tions consisted of a combination of diagnoses, medications, 
and smoking history.25 By applying stringent criteria, the 
study results show a PPV of 95% and an NPV of 96% for 
identification of asthma cases and controls, using clinician 
review as the reference standard. GWAS require a high speci-
ficity, PPV, and NPV. A high specificity was achieved but at 
the loss of 24% of the potential asthma cases.
Vollmer et al used the electronic databases of a large 
health maintenance organization to develop a case  definition 
for defining prevalent asthma and to validate it against chart 
review.26 The data systems of this organization, the Kaiser 
Permanente Northwest Division consist of both EHR (inpa-
tient data, emergency department data, EpicCare) and admin-
istrative data: “Outside claims database” and “The outpatient 
pharmacy system”. Table 2 presents the PPV of the eight 
different case definition algorithms to define asthma. The 
fourth case definition, based on a combination of an urgent 
care visit and the order of nebulizer treatment (N=25), had 
the highest PPV (100%), while the first case definition, based 
on non-urgent care visits, (N=4,460) had a PPV of 95% while 
identifying a much larger population.
Donahue et al sought to determine the reliability of iden-
tifying asthmatics through automated medical and pharmacy 
records. All adult members of the Harvard Pilgrim Health 
Care program who received an asthma diagnosis and at least 
one asthma drug between 1988 and 1991 were identified.27 
The authors manually reviewed records of a random sample 
of 100 patients to validate the asthma diagnosis. The PPV of 
a coded asthma diagnosis was 86%.
Premaratne et al measured the validity of the string “asth” 
in the accident and emergency (A&E) department attendance 
diagnosis field for identifying patients with asthma-related 
conditions attending the A&E departments of two hospitals 
in the UK in 1995.28 A reception clerk entered the diagnosis 
field in a database at arrival in the A&E department. The 
reference standard was a confirmation of the asthma diagnosis 
by a clinical officer, or symptoms of asthma plus a history 
of asthma or bronchodilators given with improvement, or a 
previously diagnosed asthmatic with symptoms or prescribed 
asthma medication. An “attendance diagnosis” of asthma 
was excluded if there was a clear alternative diagnosis or 
sufficient other evidence to exclude asthma. The string 
“asth” in the attendance diagnosis field had a sensitivity of 
80% (75%–86%) and a specificity of 97% (96%–98%) for 
a confirmation of asthma. 
Linked databases 
Our search found two studies which used a second inde-
pendent database to validate asthma diagnoses in the first 
database. The PPVs ranged from 46% to 58%.
Coulter et al30 compared repeat prescriptions for asthma, 
epilepsy, and thyroid disease with chronic disease registers 
stored on general practice computers in the early days of 
EHRs (1989). PPV of an asthma diagnosis on the register 
was 58% for asthma when using medication prescriptions as 
the reference standard.
Engeland et al evaluated the reliability of maternal 
disease registration (diabetes, asthma, and epilepsy) in the 
Medical Birth Registry of Norway (MBRN).29 The data 
they examined consisted of the EHRs of 108,489 pregnan-
cies between April 2004 and January 2007. The reference 
standard was the prescriptions in the Norwegian Prescrip-
tion Database (NorPD). The overall sensitivity of an asthma 
diagnosis in MBRN was 51% (49–52), but increasing when 
considering with a higher asthma treatment step in the 
NorPD. The sensitivity was 40% when considering records 
which only used inhaled selective beta-2-adrenoreceptor 
agonists (step1), while the sensitivity of asthma diagnosis 
Table 3 Quality assessment using QUADAS-2
Study Risk of bias
Patient  
selection
Index 
test
Reference 
standard
Flow  
and 
timing
Xi et al,19 2015 J ? J ?
Engelkes et al,20 2014 J J L J
Afzal et al,21 2013 L J J J
Dexheimer et al,22 2013 J J L J
Wu et al,23 2013,2014 L J ? J
Kozyrskyj et al,24 2009 L L J J
Pacheco et al,25 2009 L J J J
Vollmer et al,26 2004 L J J J
Donahue et al,27 1997 J L L J
Premaratne et al,28 1997 J L J J
Engeland et al,29 2009 L L L L
Coulter et al,30 1989 L L L ?
Ward et al,31 2004 L L J L
Note: Happy face: low risk; sad face: high risk; question mark: unclear risk.
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in records with systemic drugs other than adrenergics for 
obstructive airway diseases was 73%.
Questionnaires
There was only one study which used a questionnaire as the 
reference standard for database validation. 
Ward et al aimed to determine the degree of under- or 
over-reporting of the diagnosis of asthma for patients aged 
16–55 years in one large general practice in the UK.31 The 
case definition described in Table 1, (based on either codes, 
text strings or prescriptions) yielded 833 potential asthma 
cases and 831 age- and sex-matched controls from the GP 
database. A questionnaire validated for the detection of 
bronchial hyper-reactivity was sent to all asthma patients and 
their matched controls. Patients with a diagnosis of asthma 
and bronchial hyper-reactivity in the questionnaire were 
considered to have asthma. Evidence of asthma was sought 
for two groups: patients with asthma and without symptoms 
of bronchial hyper-reactivity, and controls with symptoms of 
bronchial hyper-reactivity. The results show an overall PPV 
of the case definition of 89%.
Discussion
The main finding of this review is that case definitions and 
methods of asthma diagnosis validation vary widely across 
different EHR databases. This is evident in the diversity of 
databases used by the studies, such as primary care databases, 
combined EHR and administrative databases, or data from 
nested case-control studies within larger cohorts. Some 
databases originate from a single or a few health centers, 
while others span millions of patients. The source of the 
EHR databases (primary care, secondary care, and urgent 
care) influences the case definition of asthma and the way 
the validation is conducted. Patients seeking care for asthma 
symptoms will present differently in each setting, and the test 
measures might reflect this.
Case definitions are designed with different purposes in 
mind, and each of the studied test measures (sensitivity, speci-
ficity, PPV, and NPV) have different uses. A high sensitivity is 
needed to identify all asthma patients from a database, but if 
the aim is to exclude all records of patients who do not have 
asthma, a high specificity is more important.32 The PPV is 
the proportion of true positives among all positive results: the 
patients who have asthma in the examined database who also 
have asthma according to the reference standard. The NPV 
shows the proportion of true negatives among all negative 
results: patients that do not have asthma in the database who 
also do not have asthma according the reference standard. 
PPVs and NPVs are directly related to the prevalence of 
asthma in the population. The PPV will increase with rising 
prevalence; the NPV will decrease with rising prevalence 
assuming all other factors remain constant.
Studies, the main aim of which was not database valida-
tion, were able to demonstrate a high test measure to suit their 
specific needs (PPV, NPV, sensitivity or specificity greater 
than 80%). If this was not the case, their main study results 
(not including validation) would not be reliable, and thus 
potential studies with low validity of asthma diagnosis might 
not have been conducted or published. In contrast, studies 
with a main aim of validation of asthma in databases have a 
wider range of test measures depending on the case defini-
tion. The PPV in these studies range from 46%29 to 96%.23
Manual validation was the most common reference 
standard in the validation studies included in this systematic 
review. The computer-generated case definitions studied 
recently by Engelkes et al,20 Afzal et al,21 Dexheimer et al,22 
and Wu et al23 provide ways to create algorithms with high 
sensitivities and specificities. The PPVs of these methods 
(whether a person identified as having an asthma diagnosis 
actually has asthma) might not be sufficient for all purposes 
(63%–82%). Preselected case definitions were used in five 
out of ten studies which manually validated the databases. 
The studies by Xi et al,19 Kozyrskyj et al,24 Pacheco et al,25 
Vollmer et al,26 Donahue et al,27 and Premaratne et al28 used 
this approach and all report at least one case definition algo-
rithm with a PPV above 85%. The best results arise when 
combining diagnostic data and prescription data. 
Other studies by Engeland et al29 and Coulter et al30 used 
an external data source as reference standard. This approach 
needs two databases with near complete data, so their test 
measures are reliable on the quality and  completeness of the 
two databases. It also requires that the validity of the refer-
ence standard is already known. However, they are much 
cheaper to carry out overall. Manual validation requires a 
considerable amount of time to complete, and questionnaires 
to hundreds of patients or clinicians can be expensive or 
unreliable. Coulter et al measured database completeness and 
integrity by studying different diseases including asthma. 
Their focus was not on asthma validation, but rather to 
check whether a digital database can be a valid alternative 
for analog registration. 
Typical problems of validation studies are the lack of 
availability of a reliable reference standard and the inter-
dependence of different data sources used for validation. 
There were four studies, not included in this review, which 
used face validity to compare the prevalence of asthma 
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using a case definition to the general asthma prevalence. 
This method was not considered sufficiently exact for inclu-
sion33–36 and by definition was unable to verify the validity 
of individual records.
The diagnosis of asthma can represent different condi-
tions in different regions of the world. Thus, several authors 
used an inclusive strategy and many diagnosis codes in 
order to maximize sensitivity. Researchers must weigh the 
benefits of a case-finding algorithm with high sensitivity 
against the likely lower specificity and PPV, according to 
the purpose of their research. In future studies using prede-
termined case definitions, it may be of interest to evaluate 
the predictive value of a specific set of codes validated by 
chest physicians or GPs working in the health system the 
database originates from. This group may be more accurate 
when assigning the diagnosis, and the codes applied may 
yield a much higher predictive value than when evaluating 
the same group of codes assigned by all providers. The 
PPV, NPV, sensitivity, and specificity can differ greatly 
within a single study, as shown in the studies by Xi et al,19 
Afzal et al,21 Kozyrskyj et al,24 and Vollmer et al.26 For this 
reason, the testing of multiple case definitions to obtain the 
algorithm with the highest test measure needed would be 
beneficial for future studies.
Conclusion
Asthma validation studies using EHRs are very varied in their 
approach to the validation. This seems driven by the nature of 
the data and the reference standards used. Machine-learning 
methods of algorithm development allow for measuring 
all elements of validity. Different case definitions within a 
single data source have different validity, highlighting the 
importance of testing a range of case definitions. 
Strengths and limitations of 
this study
The review of validation of asthma diagnosis codes in EHRs 
informs selection of asthma definitions used by future stud-
ies and identify any gaps in quality and scope of validation 
studies. It also provides an overview of the case definitions 
and algorithms with their PPV, NPV, sensitivity or specificity.
Validated case definition algorithms are often very spe-
cific to the database they were developed in, limiting their 
generalizability.
Publication bias might be an issue as methods that do 
not find favorable results may be less likely to have been 
published. 
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Supplementary material
Algorithm used for literature review
Asthma validation in electronic health records: a 
systematic review
MEDLINE
1 (validat* or verif*).mp. [mp=title, abstract, original title, 
name of substance word, subject heading word, keyword 
heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier]
2 (PPV or PNV or NPV or “positive predictive value*” or 
“negative predictive value*” or “predictive positive value*” 
or “predictive negative value*” or “likelihood ratio” or pre-
cision or accuracy or “receiver operating characteristic*” 
or ROC or kappa).mp. [mp=title, abstract, original title, 
name of substance word, subject heading word, keyword 
heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier]
3 Validation Studies/ or validation.mp. or validation studies 
as topic/
4 (electronic* or digital* or computeri?ed or programmed 
or automated or database or data base).mp. [mp=title, 
abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supple-
mentary concept word, rare disease supplementary con-
cept word, unique identifier]
5 asthma.mp. or Asthma/ or Asthma, Occupational/ or 
Asthma, Exercise-Induced/
6 Database Management Systems/
7 1 or 2 or 3
8 4 or 6
9 5 and 7 and 8
EMBASE
1 (validat* or verif*).mp. [mp=title, abstract, heading word, 
drug trade name, original title, device manufacturer, drug 
manufacturer, device trade name, keyword]
2 validation.mp. or validation study/ or validation process/
3 (sensitivity or specificity or “Sensitivity and Specificity”).
mp. [mp=title, abstract, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, 
device trade name, keyword]
4 (PPV or PNV or NPV or “positive predictive value” or 
“predictive negative value” or “negative predictive value” 
or “likelihood ratio” or precision or accuracy or “receiver 
operating characteristic” or ROC or kappa).mp. [mp=title, 
abstract, heading word, drug trade name, original title, 
device manufacturer, drug manufacturer, device trade 
name, keyword, floating subheading] 
5 (electronic* or digital* or computeri?ed or programmed 
or automated or database or data base).mp. [mp=title, 
abstract, heading word, drug trade name, original title, 
device manufacturer, drug manufacturer, device trade 
name, keyword]
6 mild persistent asthma/ or nocturnal asthma/ or experi-
mental asthma/ or moderate persistent asthma/ or severe 
persistent asthma/ or Asthma.mp. or exercise induced 
asthma/ or occupational asthma/ or intrinsic asthma/ or 
asthma/ or allergic asthma/ or extrinsic asthma/ or mild 
intermittent asthma/
7 1 or 2 or 3 or 4
8 5 and 6 and 7
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